Terms: = Pancreatic cancer AND SDHA, SDH2, 6389, ENSG00000073578, FP, P31040, SDHF
86 results:
1. Tff2 defines transit-amplifying pancreatic acinar progenitors that lack regenerative potential and are protective against Kras-driven carcinogenesis.
Jiang Z; Wu F; Laise P; Takayuki T; Na F; Kim W; Kobayashi H; Chang W; Takahashi R; Valenti G; Sunagawa M; White RA; Macchini M; Renz BW; Middelhoff M; Hayakawa Y; Dubeykovskaya ZA; Tan X; Chu TH; Nagar K; Tailor Y; Belin BR; Anand A; Asfaha S; Finlayson MO; Iuga AC; Califano A; Wang TC
Cell Stem Cell; 2023 Aug; 30(8):1091-1109.e7. PubMed ID: 37541213
[TBL] [Abstract] [Full Text] [Related]
2. Preoperative Chemotherapy Followed by Hepatectomy for Potentially Resectable UICC7 Stage IIIA, IIIB Hepatocellular Carcinoma; A Phase II Clinical Trial.
Goto Y; Niizeki T; Fukutomi S; Shirono T; Shimose S; Iwamoto H; Kojima S; Kanno H; Uchino Y; Sasaki S; Shirahama N; Muroya D; Nomura Y; Akashi M; Nakayama G; Hirakawa Y; Sato T; Yoshitomi M; Sakai H; Hisaka T; Kakuma T; Koga H; Torimura T; Akagi Y; Okuda K
Kurume Med J; 2023 Sep; 68(3.4):239-245. PubMed ID: 37518005
[TBL] [Abstract] [Full Text] [Related]
3. Differences in Fentanyl Requirements in Terminally Ill cancer Patients.
Watanabe A; Shimada N; Ishiki H; Fujiwara N; Nojima M; Tojo A
J Pain Palliat Care Pharmacother; 2023 Mar; 37(1):26-33. PubMed ID: 36512675
[TBL] [Abstract] [Full Text] [Related]
4. Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia.
Toledo RA; Jimenez C; Armaiz-Pena G; Arenillas C; Capdevila J; Dahia PLM
Endocr Rev; 2023 Mar; 44(2):312-322. PubMed ID: 36301191
[TBL] [Abstract] [Full Text] [Related]
5. Different neoadjuvant therapies for locally advanced rectal cancer: A systematic review and network meta-analysis.
Petrelli F; Trevisan F; Tomasello G; De Stefani A; Viti M; Garrone O; Luciani A; Ghidini M
Crit Rev Oncol Hematol; 2022 Dec; 180():103853. PubMed ID: 36252747
[TBL] [Abstract] [Full Text] [Related]
6. Residence near industrial complex and cancer incidence: A registry-based cohort of 1,022,637 participants with a follow-up of 21 years, Israel.
Kayyal-Tarabeia I; Blank M; Zick A; Agay-Shay K
Environ Res; 2023 Jan; 216(Pt 1):114471. PubMed ID: 36208787
[TBL] [Abstract] [Full Text] [Related]
7. Hetero-bivalent agents targeting FAP and PSMA.
Boinapally S; Lisok A; Lofland G; Minn I; Yan Y; Jiang Z; Shin MJ; Merino VF; Zheng L; Brayton C; Pomper MG; Banerjee SR
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4369-4381. PubMed ID: 35965291
[TBL] [Abstract] [Full Text] [Related]
8. Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine Tumors.
Cai Y; Liu Z; Jiang L; Ma D; Zhou Z; Ju H; Zhu Y
Front Endocrinol (Lausanne); 2022; 13():871830. PubMed ID: 35937823
[TBL] [Abstract] [Full Text] [Related]
9. Survey of US Medical Oncologists' Practices and Beliefs Regarding
Koo K; Pasternak AL; Henry NL; Sahai V; Hertz DL
JCO Oncol Pract; 2022 Jun; 18(6):e958-e965. PubMed ID: 35239419
[TBL] [Abstract] [Full Text] [Related]
10. The prevalence and clinical implications of pancreatic fat accumulation identified during a medical check-up.
Okada K; Watahiki T; Horie K; Takayama T; Aida Y; To K; Shida T; Ishige K; Nishiyama H; Shoda J; Suzuki H
Medicine (Baltimore); 2021 Oct; 100(41):e27487. PubMed ID: 34731128
[TBL] [Abstract] [Full Text] [Related]
11. Pilot-phase PET/CT study targeting integrin α
Nakamoto R; Ferri V; Duan H; Hatami N; Goel M; Rosenberg J; Kimura R; Wardak M; Haywood T; Kellow R; Shen B; Park W; Iagaru A; Gambhir SS
Eur J Nucl Med Mol Imaging; 2022 Dec; 50(1):184-193. PubMed ID: 34729628
[TBL] [Abstract] [Full Text] [Related]
12. Reg3A (regenerating family member 3 alpha) acts as a tumor suppressor by targeting DMBT1 (deleted in malignant brain tumors 1) in gastric cancer.
Wang L; Tuo H; Song Z; Li W; Peng Y
Bioengineered; 2021 Dec; 12(1):7644-7655. PubMed ID: 34605357
[TBL] [Abstract] [Full Text] [Related]
13. Simple cancer Stem Cell Markers Predict Neoadjuvant Chemotherapy Resistance of Esophageal Squamous Cell Carcinoma.
Agawa K; Yamashita K; Nakagawa A; Yamada K; Watanabe A; Mukohyama J; Saito M; Fujita M; Takiguchi G; Urakawa N; Hasegawa H; Kanaji S; Matsuda T; Oshikiri T; Nakamura T; Suzuki S; Kakeji Y
Anticancer Res; 2021 Aug; 41(8):4117-4126. PubMed ID: 34281882
[TBL] [Abstract] [Full Text] [Related]
14. [Chronic pancreatitis : Characterization and differentiation from pancreatic cancer].
Kristic A; Bastati N; Poetter-Lang S; Messner A; Herold A; Tamandl D; Ba-Ssalamah A
Radiologe; 2021 Jun; 61(6):563-571. PubMed ID: 34002282
[TBL] [Abstract] [Full Text] [Related]
15. Fatty Pancreas: Disease or Finding?
Silva LLSE; Fernandes MSS; Lima EA; Stefano JT; Oliveira CP; Jukemura J
Clinics (Sao Paulo); 2021; 76():e2439. PubMed ID: 33624707
[TBL] [Abstract] [Full Text] [Related]
16. Targeting STAT3 by a small molecule suppresses pancreatic cancer progression.
Chen H; Bian A; Yang LF; Yin X; Wang J; Ti C; Miao Y; Peng S; Xu S; Liu M; Qiu WW; Yi Z
Oncogene; 2021 Feb; 40(8):1440-1457. PubMed ID: 33420372
[TBL] [Abstract] [Full Text] [Related]
17. Exendin-4-based imaging in insulinoma localization: Systematic review and meta-analysis.
Shah R; Garg R; Majmundar M; Purandare N; Malhotra G; Patil V; Ramteke-Jadhav S; Lila A; Shah N; Bandgar T
Clin Endocrinol (Oxf); 2021 Aug; 95(2):354-364. PubMed ID: 33386617
[TBL] [Abstract] [Full Text] [Related]
18. Improved Antitumor Activity of the Fluoropyrimidine Polymer CF10 in Preclinical Colorectal cancer Models through Distinct Mechanistic and Pharmacologic Properties.
Gmeiner WH; Dominijanni A; Haber AO; Ghiraldeli LP; Caudell DL; D'Agostino R; Pasche BC; Smith TL; Deng Z; Kiren S; Mani C; Palle K; Brody JR
Mol Cancer Ther; 2021 Mar; 20(3):553-563. PubMed ID: 33361273
[TBL] [Abstract] [Full Text] [Related]
19. Differentiating benign and malignant pancreatic masses: Ga-68 PSMA PET/CT as a new diagnostic avenue.
Krishnaraju VS; Kumar R; Mittal BR; Sharma V; Singh H; Nada R; Bal A; Rohilla M; Singh H; Rana SS
Eur Radiol; 2021 Apr; 31(4):2199-2208. PubMed ID: 33001304
[TBL] [Abstract] [Full Text] [Related]
20. Development of a volumetric pancreas segmentation CT dataset for AI applications through trained technologists: a study during the COVID 19 containment phase.
Suman G; Panda A; Korfiatis P; Edwards ME; Garg S; Blezek DJ; Chari ST; Goenka AH
Abdom Radiol (NY); 2020 Dec; 45(12):4302-4310. PubMed ID: 32939632
[TBL] [Abstract] [Full Text] [Related]
[Next]
